Two immigration bills are on the fast track in Annapolis, but debate ended abruptly Friday in the House and the governor has ...

Rivian's first R2s — test models called manufacturing validation build vehicles — drove off the line earlier this month, with ...

The Colorado Department of Local Affairs (DOLA) announced new available incentive funding for local governments implementing ...

Forbes contributors publish independent expert analyses and insights. author of Chained to the Desk in a Hybrid World: A Guide to Balance. This voice experience is generated by AI. Learn more. This ...

In a widely anticipated move, House Republicans released a draft bill that would roll back several provisions in the nation’s premier chemical safety law with the stated goal of bolstering ...

The most consistently terrible program in the history of college football just went 16-0 to complete the most impressive ...

Report Card that tracks performance at the state’s public schools showed that six Springfield District 186 schools had ...

Brookfield Renewable Corporation ( BEPC) Q4 2025 Earnings Call January 30, 2026 9:00 AM EST Connor Teskey - CEO, Managing Partner of Brookfield & President of Brookfield Asset Management Patrick ...

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on drugs cleared under a new plan to slash FDA drug review times.

FDA delayed fast-track reviews for multiple drugs after safety and efficacy concerns, including adverse events and a reported patient death.

WASHINGTON (AP) — A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and outside experts, with some saying the poorly defined effort ...